Qube Research & Technologies (QRT)’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
BTW
Qube Research & Technologies (QRT)'s AMPH Position: Q1 2026 in Review
Qube Research & Technologies (QRT) sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2026, closing a stake of 111,439 shares — an estimated $2.98M sold.
Qube Research & Technologies (QRT) first reported a position in AMPH in Q1 2022 and held it in 15 quarters. The position peaked at $10.8M in Q2 2025. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- Qube Research & Technologies (QRT) reported no remaining Amphastar Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 111,439 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $2.98M.
- Qube Research & Technologies (QRT) first reported a position in Amphastar Pharmaceuticals in Q1 2022 and held it in 15 quarters.
- Qube Research & Technologies (QRT)'s Amphastar Pharmaceuticals position peaked at $10.8M in Q2 2025.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.